Elite Pharmaceuticals Inc (ELTP)

[Hazel2323]

This is a growing company that will have continuous increases in revenue based upon self-distributed Adderall sales and a large manufacturing contract that will commence on January 1. Two major revenue sources have filed new ANDAs, which, if and when approved, may very well cause a major pharmaceutical company to bid for the whole company. Earnings are due on November 14, with a conference call on November 15, which is also the day the poison pill expires.

Look for a breakout once the 15-cent resistance level is pierced. Next stop in the 20–25 cent range